Acrivon Therapeutics, Inc. (ACRV) stock
ACRVNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$1.40−0.16 (-10.26%)
Close on Nov 19, 2026Market cap $59.99MP/E –Yield –
Acrivon Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Acrivon Therapeutics's price to book ratio was 0.8× on Nov 11, 2026, against 0.6× a year earlier. Over the last 4 years it ranged from 0.2× to 2.6×, with a median of 0.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.8× | +0.2 |
| 2025 | Dec 31, 2025 | 0.6× | −0.4 |
| 2024 | Dec 31, 2024 | 1.0× | +0.2 |
| 2023 | Dec 29, 2023 | 0.8× | – |
See a number that looks wrong?